Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011

Infection Control and Hospital Epidemiology

Volumn 36, Issue 1, 2015, Pages 54-64

  Soe, Minn M ^a   Edwards, Jonathan R ^a   Sievert, Dawn M ^a   Ricks, Philip M ^a   Magill, Shelley S ^a   Fridkin, Scott K ^a  

^a GENERAL ELECTRIC COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; CEPHALOSPORIN; OXACILLIN; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; FEMALE; HUMAN; INFANT; INFECTION RATE; INTENSIVE CARE UNIT; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHENOTYPE; VERY ELDERLY; BACTEREMIA; CATHETER-RELATED INFECTIONS; DISEASE NOTIFICATION; DRUG EFFECTS; HEALTH SURVEY; INCIDENCE; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CARBAPENEMS; CATHETER-RELATED INFECTIONS; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INFANT; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PUBLIC HEALTH SURVEILLANCE; RISK ADJUSTMENT; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84922816868     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.11     Document Type: Article

References (33)

1. U.S. Department of health and Human Services & Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/threatreport2013/index.html. Published 2013. Accessed February 3,2014.
2. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(Suppl 2):S82-S89.
3. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008;6:751-763.
4. Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009;37:1463-1469.
5. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: European Centre for Disease Control and Prvention, 2012.
6. Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis 2013;56:1310-1318.
7. Master RN, Deane J, Opiela C, Sahm DF. Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens. Ann N Y Acad Sci 2013;1277:1-7.
8. Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005;11: 873-882.
9. Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the United States. FEMS Immunol Med Microbiol 2004;42:213-218.
10. Zilberberg MD, Shorr AF, Kollef MH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008;14:1756-1758.
11. Zhanel GG, DeCorby M, Adam H, et al. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother 2010;54:4684-4693.
12. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among Gram-negative pathogens that caused healthcareassociated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010;31: 528-531.
13. Gales AC, Jones RN, Sader HS. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2011;66:2070-2074.
14. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32(Suppl 2):S114-132.
15. Centers for Disease Control and Prevention. CDC vital signs. Making health care safer. Centers for Disease Control and Prevention website. http://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf. Accessed April 2014.
16. Siegel. JD, Rhinehart E, Jackson M, Chiarello L. Committee. THICPA. Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention website. http://www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf. Published 2006. Accessed February 3, 2014.
17. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: Resistance is a regional problem. Proc Soc Natl Acad Sci USA 2004;101:5696-5696.
18. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli Hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-855.
19. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532-540.
20. Wisconsin Division of Public Health. Guidance for preventing transmission of carbapenem-resistant Enterobacteriaceae (CRE) in acute care and long-term care hospitals. Wisconsin Division of Public Health website. http://www.dhs.wisconsin.gov/publications/P0/p00532A.pdf. Published 2014. Accessed February 3, 2014.
21. Centers for Disease Control and Prevention. National and state healthcare associated infections: Progress Report. Centers for Disease Control and Prevention website. http://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf. Published 2014. Accessed April 2014.
22. Council of state and territorial epidemiologists. Placing central line-associated bloodstream infections (CLABSI) under nationwide surveillance through the National Healthcare Safety Network (NHSN). http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/PS/12-ID-06FINAL.pdf. Accessed August 2014.
23. Virginia department of health's healthcare-associated infections (HAI) program. SYNERGY: Combining efforts for HAI prevention http://www.vdh.virginia.gov/Epidemiology/Surveillance/HAI/documents/pdf/VDH%20HAI%20NewsletterVol5Issue3FINAL.pdf. Accessed August 2014.
24. U.S. Government Accountability Office. Antibiotic Resistance: Data Gaps Will Remain Despite HHS Taking Steps to Improve Monitoring. GAO-11-406, 2011. Washington D.C. Government Accountability Office website. http://www.gao.gov/assets/320-/319110.pdf. Published 2011. Accessed February 3, 2014.
25. Centers for Disease Control and Prevention. Operational guidance for acute care hospitals to report central line-associated bloodstream infection (CLABSI) data to CDC’s NHSN for the purpose of fulfilling CMS’s hospital inpatient quality reporting (IQR) Requirements. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/HPS-manual/Operational-Guidance-HPS-Flu-Vaccination-Sum-Acute-Care.pdf. Published 2012. Accessed January 2014.
26. Rothman KJ, Boice JDJ. Epidemiologic analysis with a programmable calculator. NIH Pub No. 79-1649. Bethesda, MD: National Institutes of Health, 1979.
27. Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652-659.
28. Wolter KM. Introduction to Variance Estimation. 2nd ed. New York, NY: Springer, 2007.
29. Tillotson GS, Draghi DC, Sahm DF, Tomfohrde KM, del Fabro T, Critchley IA. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J Antimicrob Chemother 2008;62:109-115.
30. Hennekens CH, Buring JE, Mayrent SL. Epidemiology in Medicine. Boston, MA: Little, Brown and Co, 1987.
31. Kuster SP, Ruef C, Bollinger AK, et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother Oct 2008;62:837-842.
32. Magill SS, Edwards JR, Bamberg W, et al. Multi-state point prevalence survey and national burden of healthcare-associated infections. N Engl J Med 2014;370:1198-1208.
33. Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies-what are we missing? Nature Rev Microbiol 2004;2:979-983.